A 62-year-old male patient with NSTEMI is experiencing lethargy, cool diaphoretic skin, and a decrease in oxygen saturation. An echocardiogram reveals mild left ventricular systolic dysfunction with an ejection fraction of 45%. Which nursing intervention is the highest priority to address his current condition?

B) Initiate supplemental oxygen to improve oxygenation levels.

A) Administer a beta-blocker to reduce myocardial oxygen demand.

B) Initiate supplemental oxygen to improve oxygenation levels.

C) Prepare the patient for immediate coronary angiography.

D) Educate the patient on lifestyle modifications for diabetes management.

A 62-year-old male patient with NSTEMI is experiencing altered mental status, lethargy, and decreased oxygen saturation at 89% on room air. Bilateral crackles are heard on lung auscultation. Given these findings, which nursing intervention should be prioritized to address the patient's respiratory status?

C) Position the patient in a high Fowler's position to facilitate breathing

A) Administer a diuretic to reduce pulmonary congestion

B) Increase the flow rate of supplemental oxygen via nasal cannula

C) Position the patient in a high Fowler's position to facilitate breathing

D) Prepare for endotracheal intubation and mechanical ventilation

A patient receiving treatment for heart failure with pulmonary congestion is started on furosemide and supplemental oxygen. Despite initial improvement, the patient's blood pressure drops to 90/60 mmHg, and there is a consideration for inotropic support. Which nursing action is most critical in this scenario to prevent further complications?

C) Monitor for signs of electrolyte imbalance, such as hypokalemia, due to diuretic use.

A) Increase the flow rate of supplemental oxygen to improve oxygenation.

B) Administer a fluid bolus to improve blood pressure and renal perfusion.

C) Monitor for signs of electrolyte imbalance, such as hypokalemia, due to diuretic use.

D) Prepare the patient for immediate coronary angiography to assess the need for revascularization.

A patient with a history of heart failure and diabetes is receiving supplemental oxygen at 4 L/min via nasal cannula and furosemide for pulmonary congestion. The nurse notes that the patient's blood pressure has decreased to 90/60 mmHg, and the heart rate is 110 bpm. Which intervention should the nurse prioritize to address the patient's current hemodynamic status?

C) Hold the furosemide dose and notify the healthcare provider.

A) Increase the oxygen flow rate to improve oxygenation.

B) Administer a dose of intravenous inotropic medication as prescribed.

C) Hold the furosemide dose and notify the healthcare provider.

D) Increase the infusion rate of the insulin protocol to manage hyperglycemia.

A patient with NSTEMI is being managed with potassium replacement therapy due to hypokalemia induced by furosemide. The patient also has rising troponin levels and is scheduled for coronary angiography. Which nursing intervention is most critical to prioritize in this situation?

B) Assessing the patient's renal function and hydration status before administering contrast media

A) Administering potassium replacement therapy rapidly to quickly correct the hypokalemia

B) Assessing the patient's renal function and hydration status before administering contrast media

C) Monitoring the patient's blood pressure and heart rate continuously to detect changes

D) Preparing the patient for potential immediate coronary artery bypass graft surgery

A patient with NSTEMI and hypokalemia is receiving furosemide therapy. Which nursing intervention is most important to prioritize to prevent further complications?

A) Administer potassium supplements as ordered and monitor serum potassium levels.

B) Encourage the patient to increase oral fluid intake to maintain hydration.

C) Educate the patient about reducing sodium intake to manage fluid retention.

D) Position the patient in high Fowler's position to assist with breathing.

A patient with a history of myocardial ischemia and hypokalemia is experiencing hypotension and tachycardia despite potassium replacement therapy. The healthcare team is considering administering a fluid bolus and a low-dose beta-blocker. What is the priority nursing intervention when preparing to implement these interventions?

B) Monitor the patient's urine output and lung sounds before and after fluid administration.

A) Encourage the patient to increase oral fluid intake immediately.

B) Monitor the patient's urine output and lung sounds before and after fluid administration.

C) Administer the beta-blocker before ensuring the patient's blood pressure is stable.

D) Request a potassium recheck after the fluid bolus is given.

A patient with hypotension and tachycardia is experiencing premature ventricular contractions (PVCs) despite receiving potassium replacement therapy. The healthcare team is preparing for coronary angiography while stabilizing the patient's hemodynamic status. Which nursing intervention is most appropriate to prioritize at this time?

C) Initiate a cautious fluid bolus to improve blood pressure while monitoring for signs of heart failure.

A) Administer an additional dose of diuretics to manage fluid overload risk.

B) Increase the potassium replacement dose to immediately correct hypokalemia.

C) Initiate a cautious fluid bolus to improve blood pressure while monitoring for signs of heart failure.

D) Start high-dose beta-blocker therapy to rapidly control tachycardia and prevent arrhythmias.

A patient with a history of myocardial ischemia is receiving a low-dose beta-blocker to optimize cardiac output. The patient's potassium level is 3.4 mmol/L and bicarbonate level is 20 mmol/L. Which nursing intervention is most appropriate to address the patient's current clinical status?

C) Initiate potassium supplementation to correct the hypokalemia.

A) Administer an additional dose of beta-blocker to further decrease heart rate.

B) Increase intravenous fluid rate to correct the metabolic acidosis.

C) Initiate potassium supplementation to correct the hypokalemia.

D) Prepare the patient for immediate coronary angiography to assess for ischemia.

A patient with a history of myocardial ischemia is experiencing elevated heart rate, occasional PVCs, and metabolic acidosis after a fluid bolus. With a potassium level of 3.4 mmol/L, which nursing intervention should be prioritized to optimize cardiac function and prevent further complications?

B) Increase potassium supplementation to achieve a level above 4.0 mmol/L.

A) Administer additional IV fluids to correct the metabolic acidosis.

B) Increase potassium supplementation to achieve a level above 4.0 mmol/L.

C) Initiate high-dose beta-blocker therapy to control heart rate.

D) Provide supplemental oxygen to address shortness of breath.

NSTEMI - Nursing Case Study

Pathophysiology

• Primary mechanism: Partial occlusion of a coronary artery due to a ruptured atherosclerotic plaque leading to a non-occlusive thrombus. This reduces blood flow and oxygen supply to the heart muscle, causing ischemia without the full thickness myocardial necrosis seen in STEMI.

• Secondary mechanism: Endothelial dysfunction and inflammation increase platelet aggregation and thrombus formation further exacerbating the reduced blood flow, contributing to myocardial injury.

• Key complication: If untreated, NSTEMI can lead to complications such as heart failure or progress to a full-thickness myocardial infarction, necessitating prompt medical intervention to restore adequate coronary circulation.

Patient Profile

Demographics:

62-year-old male, retired construction worker

History:

• Key past medical history: Hypertension, hyperlipidemia, type 2 diabetes

• Current medications: Lisinopril, atorvastatin, metformin, aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Chest pain radiating to the left arm and jaw

• Key symptoms: Shortness of breath, nausea, diaphoresis, lightheadedness

• Vital signs: Blood pressure 150/95 mmHg, heart rate 110 bpm, respiratory rate 22 breaths/min, temperature 98.6°F, oxygen saturation 92% on room air

Section 1

As the healthcare team continues to monitor the 62-year-old male patient with NSTEMI, initial assessment findings reveal a slightly altered mental status, with the patient appearing more lethargic and having difficulty maintaining a conversation. His skin remains diaphoretic and cool to the touch, indicative of ongoing sympathetic nervous system activation due to myocardial ischemia. The patient's oxygen saturation has decreased further to 89% on room air, necessitating supplemental oxygen via nasal cannula to maintain adequate oxygenation. Lung auscultation reveals bilateral crackles at the bases, suggesting early signs of pulmonary congestion, a potential precursor to heart failure.

Laboratory tests return with elevated cardiac biomarkers, including troponin levels, confirming myocardial injury. The patient's glucose levels are noted to be elevated, at 250 mg/dL, indicating suboptimal control of his type 2 diabetes, which contributes to endothelial dysfunction and further exacerbates the ischemic process. A repeat ECG shows persistent ST-segment depression in the anterolateral leads, corroborating ongoing subendocardial ischemia without progression to a full-thickness myocardial infarction.

New diagnostic results from an echocardiogram reveal mild left ventricular systolic dysfunction with an ejection fraction of 45%, highlighting impaired cardiac contractility secondary to ischemic insult. The echocardiogram also shows mild mitral regurgitation, potentially due to ischemic papillary muscle dysfunction. These findings suggest the need for prompt coronary angiography to assess the extent of coronary artery disease and consider revascularization options to prevent further myocardial damage and the onset of heart failure. The healthcare team must balance the risks and benefits of intervention, considering the patient's comorbid conditions and current hemodynamic status, while optimizing medical therapy to stabilize his condition.

Section 2

As the healthcare team proceeds with the management of the patient, they initiate supplemental oxygen therapy at 4 L/min via nasal cannula to address the patient's hypoxemia, successfully increasing his oxygen saturation to 94%. Despite this improvement, the patient's respiratory status remains a concern due to ongoing bilateral crackles and the risk of worsening pulmonary congestion. Diuretics, such as furosemide, are considered to reduce fluid overload and alleviate symptoms of pulmonary congestion, while monitoring electrolyte levels to prevent imbalances that could further compromise cardiac function.

In the subsequent hours, the patient's condition evolves, with his blood pressure declining to 90/60 mmHg, raising concerns about potential cardiogenic shock. His heart rate remains elevated at 110 bpm, indicative of compensatory tachycardia. The healthcare team evaluates the need for intravenous inotropic support to enhance cardiac output, carefully balancing this with the risk of increasing myocardial oxygen demand. Additionally, they adjust the patient's medication regimen to include a beta-blocker, cautiously optimizing the dose to improve cardiac efficiency without exacerbating hypotension.

Meanwhile, the patient's glycemic control is addressed through the initiation of an insulin infusion protocol to manage hyperglycemia, aiming to reduce the deleterious effects of elevated glucose levels on the ischemic myocardium. As the team anticipates coronary angiography, the patient's renal function is closely monitored, given the potential nephrotoxic effects of contrast media, especially in the context of diabetes and possible volume depletion. The evolving clinical situation underscores the need for vigilant monitoring and timely decision-making to prevent the onset of heart failure and other complications, while preparing for potential revascularization procedures to restore coronary perfusion.

Section 3

As the healthcare team continues to monitor the patient, new diagnostic results from the laboratory tests reveal a significant electrolyte imbalance. The serum potassium level has dropped to 3.0 mEq/L, likely as a result of the diuretic therapy with furosemide. This hypokalemia presents a considerable risk for cardiac arrhythmias, especially in the setting of acute myocardial ischemia. The team promptly initiates potassium replacement therapy, carefully titrating the dose to avoid rapid shifts in serum levels that could further destabilize the patient's cardiac function.

In addition to the electrolyte findings, the patient's latest cardiac enzyme results show a rising troponin level, indicative of ongoing myocardial injury. This escalation prompts the healthcare team to reassess the current management plan, considering the need for urgent revascularization to prevent further myocardial damage. The elevated troponin levels, in conjunction with the patient's declining blood pressure and persistent tachycardia, suggest a worsening NSTEMI that could progress to more severe cardiac complications if not addressed.

The evolving situation requires a delicate balance between aggressive treatment and cautious monitoring. The team decides to proceed with coronary angiography, with plans for possible percutaneous coronary intervention. In preparation, they ensure that the patient is adequately hydrated to mitigate the nephrotoxic effects of contrast media, while continuing to monitor renal function closely. The decision-making process highlights the importance of integrating diagnostic findings with clinical interventions, underscoring the complexity of managing a patient with NSTEMI and evolving complications. This approach aims to stabilize the patient's condition, reduce the risk of heart failure, and ultimately improve the patient's prognosis through timely revascularization.

Section 4

As the healthcare team continues to manage the patient's condition, a change in the patient's status becomes evident. The patient's vital signs reveal a blood pressure of 88/54 mmHg, indicating hypotension, and a heart rate of 112 beats per minute, suggestive of persistent tachycardia. Despite the potassium replacement therapy, the patient begins to experience occasional premature ventricular contractions (PVCs), highlighting the need for vigilant cardiac monitoring. The team is concerned about the potential development of more significant arrhythmias due to the combination of hypokalemia and ongoing myocardial ischemia.

In response to these changes, the team evaluates the effectiveness of the current therapeutic interventions. They prioritize stabilizing the patient's hemodynamic status while preparing for the impending coronary angiography. To address the hypotension, the decision is made to administer a cautious fluid bolus, carefully balancing the risk of fluid overload, particularly in the context of possible heart failure. Additionally, the team considers initiating a low-dose beta-blocker to manage the tachycardia, provided the patient's blood pressure can be supported.

Simultaneously, further laboratory tests are ordered to reassess the patient's electrolyte status and renal function, given the recent administration of fluids and ongoing diuretic therapy. These tests will inform subsequent adjustments to the treatment plan, ensuring the patient remains stable enough to proceed with the coronary intervention. This phase of the patient's journey emphasizes the need for dynamic clinical reasoning, as the team must continuously adapt their strategies to the evolving clinical picture, aiming to prevent further complications and optimize the patient's outcome.

Section 5

As the healthcare team administers a cautious fluid bolus, the patient's blood pressure shows a modest improvement to 94/58 mmHg. However, the heart rate remains elevated at 110 beats per minute. Despite the fluid therapy, the patient continues to experience occasional PVCs, and now reports mild chest discomfort and increased shortness of breath. These symptoms raise concerns about the potential exacerbation of myocardial ischemia. With the goal of optimizing cardiac output and reducing myocardial oxygen demand, the team decides to initiate a low-dose beta-blocker cautiously, while closely monitoring the patient's hemodynamic response and ensuring adequate blood pressure support.

The latest laboratory results reveal a potassium level that has increased slightly to 3.4 mmol/L, which still remains on the lower side of normal. The serum creatinine level is stable, indicating no immediate renal impairment from the fluid administration. However, the bicarbonate level is low at 20 mmol/L, suggesting a mild metabolic acidosis, which may contribute to the patient's arrhythmias and overall clinical instability. This finding prompts the team to consider additional electrolyte management and reevaluation of the patient's acid-base status.

Given these developments, the team recognizes the need for a careful reassessment of the patient's medication regimen and electrolyte replacement strategy. They discuss the potential benefits of adjusting the potassium replacement protocol to achieve optimal levels more rapidly, while also considering the implications of the metabolic acidosis. The evolving clinical picture requires a dynamic approach to patient management, balancing the need to prepare the patient for coronary angiography with the urgency of stabilizing the current hemodynamic and cardiac status. The team prepares to reassess the patient's clinical response to these interventions, maintaining a vigilant watch for any new complications that may arise.